VAERS reports by lot

GSK Varicella/Shingles lot G933B: VAERS reports

88 VAERS reports list lot G933B as a GSK Varicella/Shingles vaccine, received between 2018-06-08 and 2021-07-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
88
Reports
8%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8325%
Injection-site / Local reaction6620%
Dermatological (non-injection-site)4814%
Musculoskeletal4614%
Neurological4313%
Gastrointestinal185%
Cardiac / Cardiovascular113%
Allergic / Anaphylactic103%
Autoimmune / Immune-mediated72%
Respiratory31%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida22
Missouri9
South Carolina8
Illinois6
Georgia6
Minnesota5
Colorado5
North Carolina3
Iowa3
Wisconsin3
New York3
Tennessee2

Reports by month received

2018-061
2018-075
2018-0853
2018-0915
2018-104
2018-112
2018-121
2019-012
2019-022
2019-041
2019-051
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.